IBNI-617

N/A

Report date: 2025/12/22 16:04:05

Base Information

Drug NameIBNI-617
Drug Alias NameIBNI617IBNI-617
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsUpdating
Therapy Area/IndicationsDepressive Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHefei Ibiome Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesHefei Ibiome Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsDepressive Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A